Higher circulating total IGF-I concentration was associated with higher overall (OR = 1.18 per 5 nmol/L increase, 95% CI: 1.05, 1.33) and possibly aggressive prostate cancer risks (OR = 1.25, 95% CI: 1.00, 1.56). The gene discussed is IGF1; the disease is prostate carcinoma.